-DOCSTART- -X- O
Acute -X- _ O
viral -X- _ O
infection -X- _ O
causes -X- _ O
damages -X- _ O
to -X- _ O
the -X- _ O
host -X- _ O
due -X- _ O
to -X- _ O
uncontrolled -X- _ O
viral -X- _ O
replication -X- _ O
but -X- _ O
even -X- _ O
replication -X- _ O
deficient -X- _ O
viral -X- _ O
vectors -X- _ O
can -X- _ O
induce -X- _ O
systemic -X- _ O
inflammatory -X- _ O
responses. -X- _ O
Indeed -X- _ O
, -X- _ O
overactive -X- _ O
host -X- _ O
innate -X- _ O
immune -X- _ O
responses -X- _ O
to -X- _ O
viral -X- _ O
vectors -X- _ O
have -X- _ O
led -X- _ O
to -X- _ O
devastating -X- _ O
consequences. -X- _ O
Macrophages -X- _ O
are -X- _ O
important -X- _ O
innate -X- _ O
immune -X- _ O
cells -X- _ O
that -X- _ O
recognize -X- _ O
viruses -X- _ O
and -X- _ O
induce -X- _ O
inflammatory -X- _ O
responses -X- _ O
at -X- _ O
the -X- _ O
early -X- _ O
stage -X- _ O
of -X- _ O
infection. -X- _ O
However -X- _ O
, -X- _ O
tissue -X- _ O
resident -X- _ O
macrophages -X- _ O
are -X- _ O
not -X- _ O
easily -X- _ O
activated -X- _ O
by -X- _ O
the -X- _ O
mere -X- _ O
presence -X- _ O
of -X- _ O
virus -X- _ O
suggesting -X- _ O
that -X- _ O
their -X- _ O
activation -X- _ O
requires -X- _ O
additional -X- _ O
signals -X- _ O
from -X- _ O
other -X- _ O
cells -X- _ O
in -X- _ O
the -X- _ O
tissue -X- _ O
in -X- _ O
order -X- _ O
to -X- _ O
trigger -X- _ O
inflammatory -X- _ O
responses. -X- _ O
Previously -X- _ O
, -X- _ O
we -X- _ O
have -X- _ O
shown -X- _ O
that -X- _ O
the -X- _ O
cross-talk -X- _ O
between -X- _ O
epithelial -X- _ O
cells -X- _ O
and -X- _ O
macrophages -X- _ O
generates -X- _ O
synergistic -X- _ O
inflammatory -X- _ O
responses -X- _ O
during -X- _ O
adenoviral -X- _ O
vector -X- _ O
infection. -X- _ O
Here -X- _ O
, -X- _ O
we -X- _ O
investigated -X- _ O
whether -X- _ O
ATP -X- _ B-Intervention
is -X- _ O
involved -X- _ O
in -X- _ O
the -X- _ O
activation -X- _ B-Intervention
of -X- _ I-Intervention
macrophages -X- _ I-Intervention
to -X- _ O
induce -X- _ O
inflammatory -X- _ O
responses -X- _ O
during -X- _ O
an -X- _ O
acute -X- _ B-Patient
adenoviral -X- _ I-Patient
infection. -X- _ I-Patient
Using -X- _ O
a -X- _ O
macrophage-epithelial -X- _ O
cell -X- _ O
co-culture -X- _ O
system -X- _ O
we -X- _ O
demonstrated -X- _ O
that -X- _ O
ATP -X- _ B-Intervention
signaling -X- _ I-Intervention
through -X- _ I-Intervention
P2X -X- _ I-Intervention
( -X- _ I-Intervention
7 -X- _ I-Intervention
) -X- _ I-Intervention
receptor -X- _ I-Intervention
( -X- _ I-Intervention
P2X -X- _ I-Intervention
( -X- _ I-Intervention
7 -X- _ I-Intervention
) -X- _ I-Intervention
R -X- _ I-Intervention
) -X- _ I-Intervention
is -X- _ O
required -X- _ B-Outcome
for -X- _ I-Outcome
induction -X- _ I-Outcome
of -X- _ I-Outcome
inflammatory -X- _ I-Outcome
mediators. -X- _ I-Outcome
We -X- _ O
also -X- _ O
showed -X- _ O
that -X- _ O
ATP-P2X -X- _ B-Intervention
( -X- _ I-Intervention
7 -X- _ I-Intervention
) -X- _ I-Intervention
R -X- _ I-Intervention
signaling -X- _ I-Intervention
regulates -X- _ B-Outcome
inflammasome -X- _ I-Outcome
activation -X- _ I-Outcome
as -X- _ I-Outcome
inhibition -X- _ I-Outcome
or -X- _ I-Outcome
deficiency -X- _ I-Outcome
of -X- _ I-Outcome
P2X -X- _ I-Outcome
( -X- _ I-Outcome
7 -X- _ I-Outcome
) -X- _ I-Outcome
R -X- _ I-Outcome
as -X- _ I-Outcome
well -X- _ I-Outcome
as -X- _ I-Outcome
caspase-1 -X- _ I-Outcome
significantly -X- _ I-Outcome
reduced -X- _ I-Outcome
IL-1β -X- _ I-Outcome
secretion. -X- _ I-Outcome
Furthermore -X- _ O
, -X- _ O
we -X- _ O
found -X- _ O
that -X- _ O
intranasal -X- _ O
administration -X- _ O
of -X- _ O
replication -X- _ O
deficient -X- _ O
adenoviral -X- _ O
vectors -X- _ O
in -X- _ O
mice -X- _ O
caused -X- _ O
a -X- _ O
high -X- _ O
mortality -X- _ O
in -X- _ O
wild-type -X- _ O
mice -X- _ O
with -X- _ O
symptoms -X- _ O
of -X- _ O
acute -X- _ O
respiratory -X- _ O
distress -X- _ O
syndrome -X- _ O
but -X- _ O
the -X- _ O
mice -X- _ B-Outcome
deficient -X- _ I-Outcome
in -X- _ I-Outcome
P2X -X- _ I-Outcome
( -X- _ I-Outcome
7 -X- _ I-Outcome
) -X- _ I-Outcome
R -X- _ I-Outcome
or -X- _ I-Outcome
caspase-1 -X- _ I-Outcome
showed -X- _ I-Outcome
increased -X- _ I-Outcome
survival. -X- _ I-Outcome
In -X- _ O
addition -X- _ O
, -X- _ O
wild-type -X- _ B-Outcome
mice -X- _ I-Outcome
treated -X- _ I-Outcome
with -X- _ I-Outcome
apyrase -X- _ I-Outcome
or -X- _ I-Outcome
inhibitors -X- _ I-Outcome
of -X- _ I-Outcome
P2X -X- _ I-Outcome
( -X- _ I-Outcome
7 -X- _ I-Outcome
) -X- _ I-Outcome
R -X- _ I-Outcome
or -X- _ I-Outcome
caspase-1 -X- _ I-Outcome
showed -X- _ I-Outcome
higher -X- _ I-Outcome
rates -X- _ I-Outcome
of -X- _ I-Outcome
survival. -X- _ I-Outcome
The -X- _ B-Outcome
improved -X- _ I-Outcome
survival -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
P2X -X- _ I-Outcome
( -X- _ I-Outcome
7 -X- _ I-Outcome
) -X- _ I-Outcome
R -X- _ I-Outcome
deficient -X- _ I-Outcome
mice -X- _ I-Outcome
correlated -X- _ I-Outcome
with -X- _ I-Outcome
diminished -X- _ I-Outcome
levels -X- _ I-Outcome
of -X- _ I-Outcome
IL-1β -X- _ I-Outcome
and -X- _ I-Outcome
IL-6 -X- _ I-Outcome
and -X- _ I-Outcome
reduced -X- _ I-Outcome
neutrophil -X- _ I-Outcome
infiltration -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
early -X- _ I-Outcome
phase -X- _ I-Outcome
of -X- _ I-Outcome
infection. -X- _ I-Outcome
These -X- _ O
results -X- _ O
indicate -X- _ O
that -X- _ O
ATP -X- _ B-Intervention
, -X- _ O
released -X- _ O
during -X- _ O
viral -X- _ O
infection -X- _ O
, -X- _ O
is -X- _ O
an -X- _ O
important -X- _ B-Outcome
inflammatory -X- _ I-Outcome
regulator -X- _ I-Outcome
that -X- _ I-Outcome
activates -X- _ I-Outcome
the -X- _ I-Outcome
inflammasome -X- _ I-Outcome
pathway -X- _ I-Outcome
and -X- _ I-Outcome
regulates -X- _ I-Outcome
inflammatory -X- _ I-Outcome
responses -X- _ I-Outcome
. -X- _ O

